HyperglycemiaBlood GlucoseDiabetic KetoacidosisDiabetes Mellitus, ExperimentalInsulinIslets of LangerhansDiabetes MellitusDiabetes Mellitus, Type 2Treatment OutcomeGlucoseHypoglycemic AgentsStreptozocinOutcome Assessment (Health Care)PrognosisRetrospective StudiesGlucose Tolerance TestTime FactorsRisk FactorsDiabetes Mellitus, Type 1HypoglycemiaProspective StudiesPregnancy OutcomeFollow-Up StudiesHyperinsulinismInsulin ResistanceGlucagonHemoglobin A, GlycosylatedInsulin-Secreting CellsDiabetes ComplicationsPredictive Value of TestsFastingPostprandial PeriodCohort StudiesAcute DiseaseSurvival AnalysisDiabetic AngiopathiesGlucose Clamp TechniqueSeverity of Illness IndexSurvival RateGlycosuriaPhlorhizinGluconeogenesisPregnancyMultivariate AnalysisGlucokinaseC-PeptideGlucose IntoleranceStrokeCritical IllnessDisease Models, AnimalBody WeightInfant, NewbornLiverDisease ProgressionDiabetic NephropathiesKaplan-Meier EstimateObesityHyperglycemic Hyperosmolar Nonketotic ComaBiological MarkersAge FactorsGlasgow Outcome ScaleSubarachnoid HemorrhageRats, Sprague-DawleyBrain IschemiaRisk AssessmentRats, ZuckerLogistic ModelsAlloxanMice, Inbred C57BLRats, WistarPregnancy in DiabeticsOxidative StressOutcome and Process Assessment (Health Care)Cerebral HemorrhagePancreasRecurrencePostoperative ComplicationsGlucagon-Like Peptide 1Hyperglycinemia, NonketoticProportional Hazards Models